Ultomiris recommended for approval in EU by CHMP for treatme

Ultomiris recommended for approval in EU by CHMP for treatment of adults with generalised myasthenia gravis

Ultomiris recommended for approval in EU by CHMP for treatment of adults with generalised myasthenia gravis

miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Milan , Lombardia , Italy , United States , United Kingdom , Massachusetts , Boston , Cambridge , Cambridgeshire , America , Istituto Neurologico Carlo Besta , Marc Dunoyer , Renato Mantegazza , Department Of Neuroimmunology , Alexion Pharmaceuticals Inc , Nasdaq , Company On Twitter Astrazeneca , Astrazeneca , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , Medicinal Products , Human Use , Myasthenia Gravis Activities , Daily Living Profile , Neuromuscular Diseases , Neurologico Carlo Besta , Chief Executive Officer , North America , Myasthenia Gravis Foundation , America Clinical Classification Class , Astrazeneca Rare Disease , Alexion Pharmaceuticals , Rare Diseases ,